Literature DB >> 28604578

Long-term Outcomes of Cochlear Implantation in Children With Congenital Cytomegalovirus Infection.

Haruo Yoshida1, Haruo Takahashi, Yukihiko Kanda, Kyoko Kitaoka, Minoru Hara.   

Abstract

OBJECTIVE: To investigate the role of the developmental delay often observed in children with congenital cytomegalovirus (CMV) infection on the improvement of language understanding after cochlear implantation (CI). STUDY
DESIGN: Retrospective chart review. PATIENTS: Sixteen children with severe and/or profound hearing loss due to congenital CMV infection (CMV group) and 107 congenitally deaf children (168 ears) without CMV infection as the cause of deafness (non-CMV group). Mean age at which patients underwent CI was 2.9 years in both groups. The mean follow-up period was 7.8 versus 8.2 years, respectively. INTERVENTIONS/MAIN OUTCOME MEASURES: The Enjoji Scale of Infant Analytical Development was used to evaluate/compare pre- and postoperative hearing level, word recognition score, speech discrimination score, and language production and perception skills. The Picture Vocabulary Test-Revised was used to assess vocabulary understanding skill. Correlation between the final vocabulary understanding skill assessment and several factors was also examined.
RESULTS: Improvement in hearing thresholds (mean: 106.0 dB) was greater after the first CI, (27-45 dB; mean: 33.8 dB) compared with hearing aid (48-74 dB; mean: 63.1 dB). Similarly, language perception and production were better in the CMV group. However, in the long term, differences between good and poor cases became prominent, especially in children with motor or cognitive delay and brain abnormalities who performed poorly in the CMV group.
CONCLUSION: Long-term language perception and production after CI were overall satisfactory in congenital CMV-deafened children. CI was effective, particularly in the absence of CMV-induced disorders. However, this effectiveness was limited in those with motor or cognitive delay.

Entities:  

Mesh:

Year:  2017        PMID: 28604578     DOI: 10.1097/MAO.0000000000001483

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  6 in total

Review 1.  Should hearing targeted screening for congenital cytomegalovirus infection Be implemented?

Authors:  Travis Haller; Angela Shoup; Albert H Park
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2020-04-23       Impact factor: 1.675

2.  Congenital human cytomegalovirus infection and neurologic diseases in newborns.

Authors:  Xin-Yan Zhang; Feng Fang
Journal:  Chin Med J (Engl)       Date:  2019-09-05       Impact factor: 2.628

3.  Postnatal Changes of Neural Stem Cells in the Mammalian Auditory Cortex.

Authors:  Zhengqing Hu; Li Tao; Meng Deng
Journal:  Int J Mol Sci       Date:  2021-02-04       Impact factor: 5.923

Review 4.  From Fetal to Neonatal Neuroimaging in TORCH Infections: A Pictorial Review.

Authors:  Giulia Lucignani; Alessia Guarnera; Maria Camilla Rossi-Espagnet; Giulia Moltoni; Amanda Antonelli; Lorenzo Figà Talamanca; Chiara Carducci; Francesca Ippolita Calo Carducci; Antonio Napolitano; Carlo Gandolfo; Francesca Campi; Cinzia Auriti; Cecilia Parazzini; Daniela Longo
Journal:  Children (Basel)       Date:  2022-08-11

5.  Characterization of Detailed Audiological Features of Cytomegalovirus Infection: A Composite Cohort Study from Groups with Distinct Demographics.

Authors:  Bong Jik Kim; Jae Joon Han; Seung Han Shin; Han-Suk Kim; Hye Ran Yang; Eun Hwa Choi; Mun Young Chang; Sang-Yeon Lee; Myung-Whan Suh; Ja-Won Koo; Jun Ho Lee; Byung Yoon Choi; Seung-Ha Oh
Journal:  Biomed Res Int       Date:  2018-08-30       Impact factor: 3.411

6.  Prediction of the Outcome of Cochlear Implantation in the Patients with Congenital Cytomegalovirus Infection based on Magnetic Resonance Imaging Characteristics.

Authors:  Jae Joon Han; Yun Jung Bae; Seul Ki Song; Jae-Jin Song; Ja-Won Koo; Jun Ho Lee; Seung Ha Oh; Bong Jik Kim; Byung Yoon Choi
Journal:  J Clin Med       Date:  2019-01-24       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.